Becton, Dickinson and Company · Class II · Cleared Dec 19, 2016
| K-number | K162081 |
| Device name | BD 1ml Luer-lok Hypodermic Syringe, BD 1 mL Luer-Lok Hypodermic Syringe with BD Hypodermic Needle or BD Eclipse Hypodermic Needle, BD 1ml Luer-lok Insulin Syringe |
| Applicant | Becton, Dickinson and Company |
| Product code | FMF |
| Device class | Class II |
| Decision date | Dec 19, 2016 |
| Decision | Substantially Equivalent |
| Regulation | 880.5860 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov